Professor Ania Jastreboff, MD, PhD Yale University provided an overview #ADA2026 of the TRIUMPH-1 trial for Retatrutide, the investigational triple G medicine from Eli Lilly and Company The unique trial design provided insights beyond #weightloss #obesity and also encompassed relevant endpoints for co-morbidities such as knee osteoarthritis and obstructive sleep apnea, two comorbidities highly sensitive to weight loss
To verify coverage, call your insurance provider or employer if you have employer-sponsored insurance
If you take it with breakfast, tea, or other medicines too soon, absorption falls and the medicine may underperform [1][2]
Some people taking GLP-1 medications (such as semaglutide, sold under the brand names Ozempic or Wegovy) have reported itchy skin after starting the new meds, writing about their experiences on message boards and social networks
Do not use medication past this date even if it looks and smells fine
2026 Mochi Health